Putnam Investments LLC Aclaris Therapeutics, Inc. Transaction History

Putnam Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $419,349 - $609,194	-29,162 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $443,547 - $547,832	-26,947 Reduced 48.03%	29,162 $582,000
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $10 Million - $15 Million	-585,733 Reduced 91.26%	56,109 $983,000
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $858,306 - $1.11 Million	-39,977 Reduced 5.86%	641,842 $15.8 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $15.7 Million - $19.6 Million	681,819	681,819 $17.6 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.